✦ LIBER ✦

Perspectives on assessing benefits and risks in clinical trials for Alzheimer’s disease

✍ Scribed by Stephen McConnell; Jason Karlawish; Bruno Vellas; Steven DeKosky

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination treatments in Alzheimer’s di

✍ Sobow, Tomasz 📂 Article 📅 2010 🏛 Expert Reviews 🌐 English ⚖ 333 KB

Defining Benefits and Risks for SERMs in

✍ SUSAN R. JOHNSON; BARBARA K. DUNN; MARIETTA ANTHONY 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Clinical relevance in drug trials for Al

✍ Alberto Spagnoli 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 2 views

Algorithms, atrophy and Alzheimer's dise

✍ Nick C. Fox; Gerard R. Ridgway; Jonathan M. Schott 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 526 KB

Adapting scales for use in global clinic

✍ Morihiro Sugishita 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Antioxidant clinical trials in mild cogn

✍ Patrizia Mecocci; Maria Cristina Polidori 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 222 KB